Search results
Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus...
Benzinga via Yahoo Finance· 6 days agoThursday, Summit Therapeutics Inc (NASDAQ:SMMT) announced that Phase 3 HARMONi-2, or AK112-303, met...
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 3 days agoA Bristol Myers Squibb Co. lung cancer treatment delayed tumor growth by less than seven weeks in a closely watched clinical trial, a disappointing result ...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 4 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
New Pathways for Treating Never-Smoker Lung Cancer | Newswise
Newswise· 3 days agoKorean joint research team have elucidated the overexpression of estrogen signaling pathways in specific Korean never-smoking lung cancer cases using multi
...PFL-002/VERT-002, a Potential Treatment for Patients with Solid Tumors, Including Non-Small Cell ...
KETK· 1 day agoFood and Drug Administration ("FDA") to initiate a first-in-human (FIH) Phase I/II clinical trial with PFL-002/VERT-002 for solid tumors including non-small cell lung < ...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters· 6 days ago, opens new tab Trodelvy failed to improve survival for patients with advanced bladder cancer and...
Bristol’s $250,000 Pill Slows Lung Cancer Growth by Seven Weeks
Bloomberg· 5 days agoHave a confidential tip for our reporters? A Bristol Myers Squibb Co. lung cancer treatment delayed...
Summit Therapeutics’ stock surges as lung-cancer treatment vies with Merck’s blockbuster
Market Watch· 7 days agoInc.’s blockbuster Keytruda in a late-stage clinical trial. The trial compared the Summit drug,...
Virtual and In-Person Palliative Care Equally Beneficial in Advanced Lung Cancer
MedPage Today· 4 days agoEarly palliative care delivered via video was as effective as in-person visits on quality-of-life...
Summit Shares Soar After Lung Cancer Drug Tops Keytruda in Study
Bloomberg· 7 days agoSummit Therapeutics Inc. shares jumped after the biotech company said a late-stage trial met its...